These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 37461096)
1. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096 [TBL] [Abstract][Full Text] [Related]
2. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
3. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers. Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532 [TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility. Lee NY; Hum M; Amali AA; Lim WK; Wong M; Myint MK; Tay RJ; Ong PY; Samol J; Lim CW; Ang P; Tan MH; Lee SC; Lee ASG Hum Genomics; 2022 Nov; 16(1):61. PubMed ID: 36424660 [TBL] [Abstract][Full Text] [Related]
5. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444 [TBL] [Abstract][Full Text] [Related]
6. A decade of RAD51C and RAD51D germline variants in cancer. Boni J; Idani A; Roca C; Feliubadaló L; Tomiak E; Weber E; Foulkes WD; Orthwein A; El Haffaf Z; Lazaro C; Rivera B Hum Mutat; 2022 Mar; 43(3):285-298. PubMed ID: 34923718 [TBL] [Abstract][Full Text] [Related]
7. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China]. Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767 [No Abstract] [Full Text] [Related]
8. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2). Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613 [TBL] [Abstract][Full Text] [Related]
9. Germline mutations in young non-smoking women with lung adenocarcinoma. Donner I; Katainen R; Sipilä LJ; Aavikko M; Pukkala E; Aaltonen LA Lung Cancer; 2018 Aug; 122():76-82. PubMed ID: 30032850 [TBL] [Abstract][Full Text] [Related]
12. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698 [TBL] [Abstract][Full Text] [Related]
13. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301 [TBL] [Abstract][Full Text] [Related]
16. Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing. Lu HM; Li S; Black MH; Lee S; Hoiness R; Wu S; Mu W; Huether R; Chen J; Sridhar S; Tian Y; McFarland R; Dolinsky J; Tippin Davis B; Mexal S; Dunlop C; Elliott A JAMA Oncol; 2019 Jan; 5(1):51-57. PubMed ID: 30128536 [TBL] [Abstract][Full Text] [Related]
17. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290 [TBL] [Abstract][Full Text] [Related]
18. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691 [TBL] [Abstract][Full Text] [Related]
19. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745 [TBL] [Abstract][Full Text] [Related]
20. The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer. Escudeiro C; Pinto C; Vieira J; Peixoto A; Pinto P; Pinheiro M; Santos C; Guerra J; Lisboa S; Santos R; Silva J; Leal C; Coimbra N; Lopes P; Ferreira M; Sousa AB; Teixeira MR Fam Cancer; 2021 Jul; 20(3):173-180. PubMed ID: 33051812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]